X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Biocon Ltd Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Biocon Ltd Quarterly Results   (BICN)

Here are the latest quarterly results of Biocon Ltd. For more details, see the Biocon Ltd financial fact sheet and Biocon Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Biocon Ltd Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m9,54110,3769,3119,3379,68610,57911,69511,238 
Other income Rs m384474432540508339675688 
Turnover Rs m9,92510,8509,7439,87710,19410,91812,37011,926 
Expenses Rs m7,1417,6157,4367,4167,8638,3629,3658,860 
Gross profit Rs m2,2482,5741,7211,9211,6202,0002,3812,378 
Depreciation Rs m683703725988936974953991 
Interest Rs m658850161138147169176 
Profit before tax Rs m1,8842,2571,3781,3121,0541,2181,9341,899 
Tax Rs m417544103376425361407521 
Profit after tax Rs m1,4671,7131,2759366298571,5271,378 
Gross profit margin %23.624.818.520.616.718.920.421.2 
Effective tax rate %22.124.17.528.740.329.621.027.4 
Net profit margin %15.416.513.710.06.58.113.112.3 
Diluted EPS Rs 2.4 2.9 2.1 1.6 1.0 1.4 2.5 2.3  
Diluted EPS (TTM) Rs 8.5 9.6 10.2 9.0 7.6 6.2 6.6 7.3  
 Subscriber Feature View   View     View      
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Biocon Ltd 1QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   NATCO PHARMA  IPCA LABS  DR. REDDYS LAB  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare BIOCON LTD With:   NATCO PHARMA  IPCA LABS  DR. REDDYS LAB  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare BIOCON LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Auto, Realty Stocks Drag(12:30 pm)

After opening the day in green share markets in India are trading on a dull note and are presently trading marginally above the dotted line.

Views on news

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (4QFY18); Net Profit Up 19.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 19.8% YoY). Sales on the other hand came in at Rs 12 bn (up 25.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Why You Should Be Excited, Not Sad, About the 30% Small Cap Crash(Profit Hunter)

Oct 4, 2018

Smallcaps have corrected over 30% since the beginning of the year. Find out why Richa Agarwal views this as an opportunity rather than a threat.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Are These Deep Corrections a Buying Signal?(Chart Of The Day)

Oct 5, 2018

The correction has bought many good companies to reasonable valuations. Go against the wisdom of crowd and Buy.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Oct 17, 2018 12:07 PM

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BIOCON LTD

BIOCON LTD - TTK HEALTHCARE COMPARISON

COMPARE BIOCON LTD WITH

MARKET STATS